This conclusion is further corroborated by a direct comparison of BMP2 with FasL, an approved factor robustly triggering programmed cell death in the myeloma cell lines highlighting the differences in the effects induced by an apoptotic factor and those observed with BMP2. Here, BMP2 is linked to plasma cell myeloma.